---

---

published : This year    tags : Biotech-beach   

save search

---

Neurocrine Biosciences Reports Positive Phase 2 Data for NBI-1065845 in Adults with Major Depressive Disorder
Published: 2024-04-23 (Crawled : 13:30) - biospace.com/
TAK | News | $13.35 -0.08% 230K |

Health Technology

| 0.0% | O: -0.11% H: 0.0% C: 0.0%
NBIX | News M | $141.21 5.65% 490K |

Health Technology

| 0.0% | O: 5.43% H: 0.0% C: 0.0%
nbi-1065 positive for

---

Acadia Pharmaceuticals Announces Trofinetide New Drug Submission for Treatment of Rett Syndrome Has Been Accepted for Filing and Priority Review by Health Canada
Published: 2024-04-22 (Crawled : 14:00) - biospace.com/
ACAD | News | $16.99 110K |

Health Technology

| 1.01% | O: 1.37% H: 1.7% C: -0.35%
drug health review treatment pharmaceuticals for canada submission

---

Poseida Therapeutics Announces Strong Lineup of Presentations at the American Society of Gene and Cell Therapy 27th Annual Meeting
Published: 2024-04-18 (Crawled : 19:00) - biospace.com/
PSTX | $2.255 4.64% 41K |

Health Technology

| 5.39% | O: 0.25% H: 0.0% C: 0.0%
cell meeting therapeutics therapy

---

Nexcella, an Immix Biopharma Subsidiary, on Track to Dose NXC-201 Patients in United States
Published: 2024-04-18 (Crawled : 19:00) - biospace.com/
IMMX | $2.135 0.24% 3.7K |

| -14.8% | O: -3.6% H: 0.0% C: 0.0%
nxc-201 biopharma

---

Acadia Pharmaceuticals Presents New DAYBUE™ (trofinetide) Clinical Data at the 2024 American Academy of Neurology (AAN) Annual Meeting
Published: 2024-04-17 (Crawled : 23:00) - biospace.com/
ACAD | News | $16.99 110K |

Health Technology

| -0.53% | O: 0.76% H: 0.0% C: 0.0%
neurology pharmaceuticals meeting

---

Poseida Therapeutics Hosts Gene Therapy R&D Day Highlighting New Scientific Advancements and Pipeline Focus
Published: 2024-04-17 (Crawled : 15:00) - biospace.com/
PSTX | $2.255 4.64% 41K |

Health Technology

| 5.91% | O: 0.0% H: 2.46% C: 0.49%
day pipeline therapeutics therapy

---

Evoke Pharma to Host Virtual Key Opinion Leader (KOL) Webinar on the Evolving Landscape of Gastroparesis
Published: 2024-04-17 (Crawled : 15:00) - biospace.com/
EVOK | $0.455 34 |

Health Technology

| Email alert Add to watchlist
pharma key

---

Sentynl Therapeutics Receives MHRA Authorization of NULIBRY® (fosdenopterin) for Treatment of MoCD Type A in Great Britain
Published: 2024-04-16 (Crawled : 16:00) - biospace.com/
BBIO | $25.865 3.17% 160K |

Health Technology

| -2.72% | O: -1.47% H: 2.05% C: -0.59%
nulibry authorization treatment for therapeutics

---

New Topline Efficacy Data from the enVVeno Medical VenoValve(R) Pivotal Trial to be Presented at the 46th Annual Charing Cross Symposium on April 24, 2024
Published: 2024-04-16 (Crawled : 14:00) - biospace.com/
NVNO | $5.15 4.89% 26K |

Manufacturing

| -0.2% | O: -1.22% H: 0.0% C: -2.06%
symposium topline medical trial

---

Cutera® Announces the North America Launch of xeo®+
Published: 2024-04-11 (Crawled : 21:00) - biospace.com/
CUTR | $2.01 3.61% 210K |

Health Technology

| 10.86% | O: -1.71% H: 13.36% C: 12.21%
cutera america

---

Blacksmith Medicines To Highlight Preclinical Oncology Data Demonstrating a Potent and Selective FEN1 Inhibitor Has Synergy with Multiple DDR Drug Classes at AACR Annual Meeting 2024
Published: 2024-04-10 (Crawled : 22:00) - biospace.com/
LLY | News | $739.11 1.06% 320K |

Health Technology

| -3.42% | O: -0.71% H: 0.0% C: 0.0%
drug preclinical meeting

---

MEI Pharma to Present at the Stifel 2024 Virtual Targeted Oncology Forum
Published: 2024-04-10 (Crawled : 12:30) - biospace.com/
MEIP | $3.31 -1.78% 3.9K |

Health Technology

| -11.78% | O: 0.0% H: 0.52% C: -1.57%
pharma

---

QuidelOrtho Adds Fentanyl Test to Its Vitros® Systems as a MicroTip® Partnership Assay
Published: 2024-04-10 (Crawled : 12:30) - biospace.com/
QDEL | News M | $39.905 2.11% 420K |

Health Technology

| -12.44% | O: -2.64% H: 2.3% C: 1.24%
vitros partnership test assay

---

Tandem Diabetes Care to Announce First Quarter 2024 Financial Results on May 2, 2024
Published: 2024-04-09 (Crawled : 00:00) - biospace.com/
TNDM | $33.74 6.34% 560K |

Health Technology

| -5.42% | O: 0.3% H: 4.7% C: 3.68%
first care diabetes financial results

---

Poseida Therapeutics Presents New Phase 1 Data at AACR 2024 Supporting Potential of P-BCMA-ALLO1 Allogeneic CAR-T Therapy to Benefit Broad Range of Patients with Multiple Myeloma
Published: 2024-04-08 (Crawled : 00:00) - biospace.com/
PSTX | $2.255 4.64% 41K |

Health Technology

| -28.09% | O: -0.67% H: 0.0% C: 0.0%
car-t therapeutics potential therapy

---

Thermo Fisher Scientific Launches New ENERGY STAR certified TSX Universal Series ULT Freezers to Deliver Tighter Temperature Control and Faster Recovery Times
Published: 2024-04-08 (Crawled : 14:00) - biospace.com/
TMO | News | $572.645 4.43% 800K |

Health Technology

| -5.36% | O: 0.06% H: 0.0% C: 0.0%
tsx energy universal control series certified star

---

STAAR Surgical Announces Preliminary Net Sales for First Quarter 2024
Published: 2024-04-04 (Crawled : 19:00) - biospace.com/
STAA | $47.62 2.3% 160K |

Health Technology

| 19.15% | O: 12.52% H: 6.73% C: 3.53%
sales first

---

Fate Therapeutics to Present at 23rd Annual Needham Virtual Healthcare Conference
Published: 2024-04-03 (Crawled : 19:00) - biospace.com/
FATE | News | $4.915 2.82% 260K |

Health Technology

| -29.71% | O: -0.29% H: 7.52% C: 3.39%
conference therapeutics

---

Longboard Pharmaceuticals to Present Late-Breaking Data from the PACIFIC Study at the American Academy of Neurology (AAN) Annual Meeting on April 15
Published: 2024-04-03 (Crawled : 19:00) - biospace.com/
LBPH | $20.1 7.66% 88K |

Manufacturing

| -5.61% | O: -0.61% H: 0.61% C: -7.83%
pharmaceuticals meeting study

---

Blacksmith Medicines to Present at the 23rd Annual Needham Healthcare Conference
Published: 2024-04-03 (Crawled : 15:00) - biospace.com/
LLY | News | $739.11 1.06% 320K |

Health Technology

| -4.27% | O: 0.76% H: 0.0% C: 0.0%
conference

---

Gainers vs Losers

89%

11%

Top 10 Gainers

MTTR | News M | $4.65 167.24% 9.8M |

AGBA | $2.46 96.8% 28M |

Finance

EDBL | News | $6.94 84.57% 1.4M |

CZOO | $7.74 55.11% 2.7M |

VNRX | $0.84 40.0% 2.6M |

Health Technology

ZAPP | $6.02 35.59% 95K |

n/a

OPRT | News | $3.01 33.78% 6.8M |

Finance

MLEC | $1.81 29.29% 2M |

n/a

MTC | $2.0 28.21% 1.7M |

Technology Services

PEGY | $0.0586 27.95% 130M |

Manufacturing

---

Your saved searches

---